Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ClearPoint Neuro, Inc. (CLPT) had Revenue of $8.86M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$8.86M
Net Income	$-5.89M
Cost of Goods Sold	$3.26M
Gross Profit	$5.60M
Operating Expenses	$14.14M
Operating Income	$-5.28M
Non-Operating Income/Expense	$-0.61M
Pre-Tax Income	$-5.88M
Normalized Pre-Tax Income	$-5.88M
Income after Taxes	$-5.89M
Income from Continuous Operations	$-5.89M
Consolidated Net Income/Loss	$-5.89M
Normalized Income after Taxes	$-5.89M
EBIT	$-5.28M
EBITDA	$-4.81M
Weighted-Average Shares Outstanding (Basic)	28.43M
Weighted-Average Shares Outstanding (Diluted)	28.43M
Earnings per Share (EPS) (Basic)	$-0.21
Earnings per Share (EPS) (Diluted)	$-0.21
Balance Sheet Financials
Current Assets	$51.33M
Property, Plant, and Equipment	$2.11M
Long-Term Assets	$9.03M
Total Assets	$60.36M
Current Liabilities	$8.05M
Long-Term Debt	$29.20M
Long-Term Liabilities	$36.43M
Total Liabilities	$44.48M
Common Equity	$15.87M
Tangible Shareholders Equity	$15.87M
Shareholders Equity	$15.87M
Common Shares Outstanding	28.43M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-11.85M
Cash Flow from Investing Activities	$-0.47M
Cash Flow from Financial Activities	$30.61M
Beginning Cash	$20.10M
End Cash	$38.40M
Increase/Decrease in Cash	$18.30M
Stock-Based Compensation	$6.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.65
Debt to Equity Ratio	1.84
Gross Margin	63.20%
Operating Margin	-59.54%
EBIT Margin	-59.54%
EBITDA Margin	--
Pre-Tax Profit Margin	-66.39%
Profit Margin	-66.48%
Free Cash Flow	$-12.32M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.50
Receiveable Turnover	2.22
Days Sales in Receivables	40.63
Return on Equity	-37.11%
Return on Tangible Equity	-37.11%
Return on Assets	-9.76%
Return on Investments	-13.07%
Book Value Per Share	$0.56
Free Cash Flow per Share	$-0.43
Operating Cash Flow per Share	$-0.42

Data from Zacks Investment Research, Inc.